Uptake of doxorubicin by cultured kidney epithelial cells LLC-PK1. 1998

M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Japan.

The renal handling of doxorubicin (DXR) was investigated using a kidney epithelial cell line, LLC-PK1. The uptake of DXR by LLC-PK1 cells cultured on plastic dishes was shown to be temperature and concentration dependent. The initial uptake of DXR was slightly saturable. The Km and Vmax of the saturable component were calculated to be 20.2 microM, and 0.355 nmol/mg protein/10 min, respectively. The release of DXR from LLC-PK1 cells was very slow at 37 degrees C and almost negligible at 4 degrees C, indicating that most of the DXR in the cells irreversibly binds to cellular constituents and that only a slight amount of unbound DXR participates in the efflux out of the cells. DXR uptake at 37 degrees C was significantly decreased in the presence of 2,4-dinitrophenol. However, organic cations and aminoglycoside antibiotics, such as tetraethylammonium, N1-methylnicotinamide, guanidine, gentamicin and neomycin, did not inhibit DXR uptake, suggesting that a process distinct from the organic cation transport system and absorptive endocytosis might be involved in the uptake of DXR by LLC-PK1 cells.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite

Related Publications

M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
October 1984, Archives of biochemistry and biophysics,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
March 1988, Biochimica et biophysica acta,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
March 1992, The American journal of physiology,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
July 1998, The Journal of pharmacology and experimental therapeutics,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
June 1996, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
August 1997, Biological & pharmaceutical bulletin,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
February 1984, Journal of cellular physiology,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
July 1989, The American journal of physiology,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
June 1992, The Journal of pharmacology and experimental therapeutics,
M Sasaya, and I Wada, and M Shida, and M Sato, and Y Hatakeyama, and H Saitoh, and M Takada
July 1983, The American journal of physiology,
Copied contents to your clipboard!